Breast Implant Patient Follow-Up Data Collection Crucial – FDA Guidance
This article was originally published in The Gray Sheet
Executive Summary
Breast implant manufacturers should offer incentives in order to encourage patient cooperation with post-implant study data collection efforts, FDA advises in a final guidance document
You may also be interested in...
NCI Silicone Breast Implant Study Will Assess Connective Tissue Disease
Follow-up analyses of a 13,500-patient silicone breast implant study will evaluate the relationship of the devices to connective tissue diseases (CTD), according to a 1report submitted to Congress by the National Institutes of Health April 24
NCI Silicone Breast Implant Study Will Assess Connective Tissue Disease
Follow-up analyses of a 13,500-patient silicone breast implant study will evaluate the relationship of the devices to connective tissue diseases (CTD), according to a 1report submitted to Congress by the National Institutes of Health April 24
FDA, Congress Examine Saline Implant Data; Silicone PMA Expected In 2002
Mentor and Inamed should reconvene focus groups to review patient labeling changes for saline-filled breast implants, FDA's General and Plastic Surgery Devices Panel recommended July 9 at its meeting in Gaithersburg, Maryland